Switzerland Drug Delivery Devices Investment Opportunities, Analysis and Forecas

ts to 2017 , a new report by Global Markets Direct, provides key market data on t
he Switzerland Drug Delivery Devices market. The report provides value (USD mill
ion), volume (units) and average price (USD) data for each segment and sub-segme
nt within four market categories  Central Venous Catheters, Infusion Systems, Inh
alation Systems, Metered Dose Inhaler Devices and Needle Free Injections. The re
port also provides company shares and distribution shares data for each of the a
forementioned market categories. The report is supplemented with global corporat
e-level profiles of the key market participants with information on key recent d
evelopments.
This report is built using data and information sourced from proprietary databas
es, primary and secondary research and in-house analysis by Global Markets Direc
t's team of industry experts.
Scope
- Market size and company share data for Drug Delivery Devices market categories
 Central Venous Catheters, Infusion Systems, Inhalation Systems, Metered Dose In
haler Devices and Needle Free Injections.
- Annualized market revenues (USD million), volume (units) and average price (US
D) data for each of the segments and sub-segments within four market categories.
Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the four market c
ategories.
- Global corporate-level profiles of key companies operating within the Switzerl
and Drug Delivery Devicesmarket.
- Key players covered include GlaxoSmithKline plc, Boehringer Ingelheim GmbH, As
traZeneca PLC, Sunovion, Baxter International Inc., Teleflex Incorporated, B. Br
aun Melsungen AG and others.
Reasons to buy
- Develop business strategies by identifying the key market categories and segme
nts poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Switzerla
nd Drug Delivery Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments e
xpected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of p
roduct distribution  Identify, understand and capitalize.
for more detail you can go here http://ordermarketreports.com/product_info.php?p
roducts_id=980
Website http://www.ordermarketreports.com/

1.1 List of Tables

Table 1: Drug Delivery Devices, Switzerland, Overall Revenue ($m), 2003-2017 11
Table 2: Drug Delivery Devices, Switzerland, Overall Revenue ($m), Historic, 200
3-2010 13
Table 3: Drug Delivery Devices, Switzerland, Overall Revenue ($m), Forecast, 201
0-2017 15
Table 4: Drug Delivery Devices, Switzerland, Category Volume (Units), 2003-2017
16
Table 5: Drug Delivery Devices, Switzerland, Category Volume (Units), Historic,
2003-2010 18
Table 6: Drug Delivery Devices, Switzerland, Category Volume (Units), Forecast,
2010-2017 20
Table 7: Drug Delivery Devices, Switzerland, Company Share by Revenue ($m), 2009
-2010 22
Table 8: Central Venous Catheters, Switzerland, Revenue ($m) by Segment, Histori
c, 2003-2010 24
Table 9: Central Venous Catheters, Switzerland, Revenue ($m) by Segment, Forecas
t, 2010-2017 26
Table 10: Central Venous Catheters, Switzerland, Volume (Units) by Segment, Hist
oric, 2003-2010 28
Table 11: Central Venous Catheters, Switzerland, Volume (Units) by Segment, Fore
cast, 2010-2017 29
Table 12: Central Venous Catheters, Switzerland, Average Price ($), Historic, 20
03-2010 30
Table 13: Central Venous Catheters, Switzerland, Average Price ($), Forecast, 20
10-2017 30
Table 14: Central Venous Catheters, Switzerland, Distribution Share by Revenue (
$m), 2009-2010 31
Table 15: Central Venous Catheters, Switzerland, Company Share by Revenue ($m),
2009-2010 33
Table 16: Infusion Systems, Switzerland, Revenue ($m) by Segment, Historic, 2003
-2010 35
Table 17: Infusion Systems, Switzerland, Revenue ($m) by Segment, Forecast, 2010
-2017 37
Table 18: Syringe Pumps, Switzerland, Revenue ($m) by Sub-Segment, Historic, 200
3-2010 38
Table 19: Syringe Pumps, Switzerland, Revenue ($m) by Sub-Segment, Forecast, 201
0-2017 39
Table 20: Ambulatory Infusion Pumps, Switzerland, Revenue ($m) by Sub-Segment, H
istoric, 2003-2010 41
Table 21: Ambulatory Infusion Pumps, Switzerland, Revenue ($m) by Sub-Segment, F
orecast, 2010-2017 42
Table 22: Infusion Systems, Switzerland, Volume (Units) by Segment, Historic, 20
03-2010 44
Table 23: Infusion Systems, Switzerland, Volume (Units) by Segment, Forecast, 20
10-2017 46
Table 24: Syringe Pumps, Switzerland, Volume (Units) by Sub-Segment, Historic, 2
003-2010 48
Table 25: Syringe Pumps, Switzerland, Volume (Units) by Sub-Segment, Forecast, 2
010-2017 49
Table 26: Ambulatory Infusion Pumps, Switzerland, Volume (Units) by Sub-Segment,
Historic, 2003-2010 51
Table 27: Ambulatory Infusion Pumps, Switzerland, Volume (Units) by Sub-Segment,
Forecast, 2010-2017 53
Table 28: Infusion Systems, Switzerland, Average Price ($), Historic, 2003-2010
54
Table 29: Infusion Systems, Switzerland, Average Price ($), Forecast, 2010-2017
54
Table 30: Infusion Systems, Switzerland, Distribution Share by Revenue ($m), 200
9-2010 55
Table 31: Infusion Systems, Switzerland, Company Share by Revenue ($m), 2009-201
0 57
Table 32: Metered Dose Inhaler Devices, Switzerland, Revenue ($m) Historic, 2003
-2010 58
Table 33: Metered Dose Inhaler Devices, Switzerland, Revenue ($m) Forecast, 2010
-2017 59
Table 34: Metered Dose Inhaler Devices, Switzerland, Volume (Units) Historic, 20
03-2010 60
Table 35: Metered Dose Inhaler Devices, Switzerland, Volume (Units), Forecast, 2
010-2017 61
Table 36: Metered Dose Inhaler Devices, Switzerland, Average Price ($), Historic
, 2003-2010 62
Table 37: Metered Dose Inhaler Devices, Switzerland, Average Price ($), Forecast
, 2010-2017 62
Table 38: Metered Dose Inhaler Devices, Switzerland, Distribution Share by Reven
ue ($m), 2009-2010 63
Table 39: Metered Dose Inhaler Devices, Switzerland, Company Share by Revenue ($
m), 2009-2010 64
Table 40: Needle Free Injections, Switzerland, Revenue ($m) Historic, 2003-2010
65
Table 41: Needle Free Injections, Switzerland, Revenue ($m) Forecast, 2010-2017
66
Table 42: Needle Free Injections, Switzerland, Volume (Units) Historic, 2003-201
0 67
Table 43: Needle Free Injections, Switzerland, Volume (Units) Forecast, 2010-201
7 68
Table 44: Needle Free Injections, Switzerland, Average Price ($), Historic, 2003
-2010 69
Table 45: Needle Free Injections, Switzerland, Average Price ($), Forecast, 2010
-2017 69
Table 46: Needle Free Injections, Switzerland, Distribution Share by Revenue ($m
), 2009-2010 70
Table 47: Needle Free Injections, Switzerland, Company Share by Revenue ($m), 20
09-2010 71
Table 48: USD to Local Currency, Switzerland, Average Actual Rate 2003-2010 85

1.2 List of Figures

Figure 1: Drug Delivery Devices, Switzerland, Overall Revenue ($m), 2003-2017 10
Figure 2: Drug Delivery Devices, Switzerland, Overall Revenue ($m), Historic, 20
03-2010 12
Figure 3: Drug Delivery Devices, Switzerland, Overall Revenue ($m), Forecast, 20
10-2017 14
Figure 4: Drug Delivery Devices, Switzerland, Category Volume (Units), 2003-2017
16
Figure 5: Drug Delivery Devices, Switzerland, Category Volume (Units), Historic,
2003-2010 17
Figure 6: Drug Delivery Devices, Switzerland, Category Volume (Units), Forecast,
2010-2017 19
Figure 7: Drug Delivery Devices, Switzerland, Company Share (%), 2010 21
Figure 8: Central Venous Catheters, Switzerland, Revenue ($m) by Segment, Histor
ic, 2003-2010 23
Figure 9: Central Venous Catheters, Switzerland, Revenue ($m) by Segment, Foreca
st, 2010-2017 25
Figure 10: Central Venous Catheters, Switzerland, Volume (Units) by Segment, His
toric, 2003-2010 27
Figure 11: Central Venous Catheters, Switzerland, Volume (Units) by Segment, For
ecast, 2010-2017 29
Figure 12: Central Venous Catheters, Switzerland, Company Share (%), 2010 32
Figure 13: Infusion Systems, Switzerland, Revenue ($m) by Segment, Historic, 200
3-2010 34
Figure 14: Infusion Systems, Switzerland, Revenue ($m) by Segment, Forecast, 201
0-2017 36
Figure 15: Syringe Pumps, Switzerland, Revenue ($m) by Sub-Segment, Historic, 20
03-2010 38
Figure 16: Syringe Pumps, Switzerland, Revenue ($m) by Sub-Segment, Forecast, 20
10-2017 39
Figure 17: Ambulatory Infusion Pumps, Switzerland, Revenue ($m) by Sub-Segment,
Historic, 2003-2010 40
Figure 18: Ambulatory Infusion Pumps, Switzerland, Revenue ($m) by Sub-Segment,
Forecast, 2010-2017 42
Figure 19: Infusion Systems, Switzerland, Volume (Units) by Segment, Historic, 2
003-2010 43
Figure 20: Infusion Systems, Switzerland, Volume (Units) by Segment, Forecast, 2
010-2017 45
Figure 21: Syringe Pumps, Switzerland, Volume (Units) by Sub-Segment, Historic,
2003-2010 47
Figure 22: Syringe Pumps, Switzerland, Volume (Units) by Sub-Segment, Forecast,
2010-2017 49
Figure 23: Ambulatory Infusion Pumps, Switzerland, Volume (Units) by Sub-Segment
, Historic, 2003-2010 50
Figure 24: Ambulatory Infusion Pumps, Switzerland, Volume (Units) by Sub-Segment
, Forecast, 2010-2017 52
Figure 25: Infusion Systems, Switzerland, Company Share (%), 2010 56
Figure 26: Metered Dose Inhaler Devices, Switzerland, Revenue ($m) Historic, 200
3-2010 58
Figure 27: Metered Dose Inhaler Devices, Switzerland, Revenue ($m) Forecast, 201
0-2017 59
Figure 28: Metered Dose Inhaler Devices, Switzerland, Volume (Units) Historic, 2
003-2010 60
Figure 29: Metered Dose Inhaler Devices, Switzerland, Volume (Units), Forecast,
2010-2017 61
Figure 30: Metered Dose Inhaler Devices, Switzerland, Company Share (%), 2010 64
Figure 31: Needle Free Injections, Switzerland, Revenue ($m) Historic, 2003-2010
65
Figure 32: Needle Free Injections, Switzerland, Revenue ($m) Forecast, 2010-2017
66
Figure 33: Needle Free Injections, Switzerland, Volume (Units) Historic, 2003-20
10 67
Figure 34: Needle Free Injections, Switzerland, Volume (Units) Forecast, 2010-20
17 68
Figure 35: Needle Free Injections, Switzerland, Company Share (%), 2010 71
Figure 36: Global Markets Direct Methodology 80